These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 8191435)

  • 1. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):341-5. PubMed ID: 8191435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical mass screening in Norway--510,000 smears a year.
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Cancer Detect Prev; 1994; 18(6):463-70. PubMed ID: 7867019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mass screening for cervical cancer. Experiences after 25 years of voluntary screening and 2 years of organized screening].
    Thoresen SO; Skare GB; Sandvin O
    Tidsskr Nor Laegeforen; 1997 Aug; 117(18):2613-5. PubMed ID: 9324815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Are analyses of cytological cervix smears from young women more harmful than beneficial?].
    Skjeldestad FE; Hagen B; Hagmar B; Iversen OE; Juvkam KH; Steen R; Thoresen S; Hareide B
    Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1782-5. PubMed ID: 17599128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
    Nygård M; Daltveit AK; Thoresen SO; Nygård JF
    BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence and mortality of uterine cervix cancer in Norway. When do we get organized nation-wide cytologic screening in Norway?].
    Magnus K; Langmark F
    Tidsskr Nor Laegeforen; 1990 May; 110(12):1557-9. PubMed ID: 2187277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening: A Slovenian experience.
    Primic-Zakelj M; Repse-Fokter A
    Coll Antropol; 2007 Apr; 31 Suppl 2():23-6. PubMed ID: 17600934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening programme in Primorsko-Goranska County, Croatia--the results of the pilot study.
    Vrdoljak-Mozetic D; Ostojić DV; Stemberger-Papić S; Janković S; Glibotić-Kresina H; Brncić-Fischer A; Benić-Salamon K
    Coll Antropol; 2010 Mar; 34(1):225-32. PubMed ID: 20437641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
    Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
    Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ; Chirenje ZM
    Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Campaign for cervical cancer screening with vaginal smears in women aged 50-69 years in Isère (France). Results of the first round (January 1991-June 1993)].
    Garnier A; Exbrayat C; Bolla M; Marron J; Winckel P; Billette de Villemeur A
    Bull Cancer; 1997 Aug; 84(8):791-5. PubMed ID: 9339183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Fitzroy Valley Pap Smear Register. Cervical screening in a population of Australian aboriginal women.
    Mak DB; Straton JA
    Med J Aust; 1993 Feb; 158(3):163-6. PubMed ID: 8450781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring the performance of New Zealand's National Cervical Screening Programme through data linkage.
    Lewis H; Yeh LC; Almendral B; Neal H
    N Z Med J; 2009 Oct; 122(1305):15-25. PubMed ID: 19966874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass screening for cervical cancer in Norway: evaluation of the pilot project.
    Bjørge T; Gunbjørud AB; Haugen OA; Skare GB; Tropé C; Thoresen SO
    Cancer Causes Control; 1995 Nov; 6(6):477-84. PubMed ID: 8580294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of Papanicolaou screening in Sweden: record linkage between a central screening registry and the National Cancer Registry.
    Pettersson F; Näslund I; Malker B
    IARC Sci Publ; 1986; (76):91-105. PubMed ID: 3570419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.